techniques provide means to assess multiple MS-related pathologies, including axonal injury, demyelination, and inflammation. A method to directly and non-invasively probe white-matter function could further elucidate the interplay of underlying pathologies and functional impairments. Previously, we demonstrated a significant 27% activation-associated decrease in the apparent diffusion coefficient of water perpendicular to the axonal fibers (ADC ⊥ ) in normal C57BL/6 mouse optic nerve with visual stimulation using diffusion fMRI. Here we apply this approach to explore the relationship between visual acuity, optic nerve pathology, and diffusion fMRI in the experimental autoimmune encephalomyelitis (EAE) mouse model of optic neuritis. Visual stimulation produced a significant 25% (vs. baseline) ADC ⊥ decrease in sham EAE optic nerves, while only a 7% (vs. baseline) ADC ⊥ decrease was seen in EAE mice with acute optic neuritis. The reduced activation-associated ADC ⊥ response correlated with post-MRI immunohistochemistry determined pathologies (including inflammation, demyelination, and axonal injury). The negative correlation between activation-associated ADC ⊥ response and visual acuity was also found when pooling EAE-affected and sham groups under our experimental criteria. Results suggest that reduction in diffusion fMRI directly reflects impaired axonal-activation in EAE mice with optic neuritis. Diffusion fMRI holds promise for directly gauging in vivo white-matter dysfunction or therapeutic responses in MS patients.
Introduction
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the brain, optic nerve, and spinal cord (Compston and Coles, 2008; Filippi et al., 2012; Trapp and Nave, 2008) . Optic neuritis is a frequent first sign of MS, which produces blurred vision and/or pain in the affected eye due to inflammation and demyelination at foci within optic nerve (Arnold, 2005; Beck et al., 2003; Brodsky et al., 2008) . Experimental autoimmune encephalomyelitis (EAE) induced by inoculation of myelin oligodendrocyte glycoprotein (MOG) peptide is a widely used animal model of human MS. Many features of the pathology in this EAE model resemble those characteristic of MS, including inflammation, demyelination, and axonal injury and loss (Diem et al., 2008; Emerson et al., 2009; Gold et al., 2006; Sun et al., 2007) .
Magnetic resonance imaging (MRI) is routinely used to detect and quantify pathologies in EAE animal models and MS patients (Emerson et al., 2009; Filippi, 2003; Filippi et al., 2012; Ge, 2006; Inglese and Bester, 2010) . For instance, diffusion-MRI-derived axial diffusivity, radial diffusivity, fractional anisotropy, and mean diffusivity have been used to identify axonal injury, demyelination, inflammation, and axonal loss (Naismith et al., 2010; Roosendaal et al., 2009; Song et al., 2005; Sun et al., 2007; Wu et al., 2007) . Abnormal T2-weighted hyperintensities within white matter may reflect several pathologies, including inflammation, demyelination, and axonal loss (Bruck et al., 1997; Sahraian and Eshaghi, 2010) . Significant axon loss can lead to persistent T1-weighted hypointensities (van Walderveen et al., 1998) . T1-weighted gadolinium contrast-enhancement is indicative of compromised blood-brain barrier (BBB), which is associated with inflammation in EAE models and MS (Boretius et al., 2008; Broom et al., 2005; Bruck et al., 1997; Filippi et al., 1995; Nessler et al., 2007) . More accurate and novel approaches have recently been introduced to distinguish coexisting inflammation, Neurobiology of Disease 67 (2014) 1-8
